The DOI matches its Crossref record; 269 of the 275 references it cites were found in a registry or an index.
The evolution of commercial drug delivery technologies
Abstract
Drug delivery technologies have enabled the development of many pharmaceutical products that improve patient health by enhancing the delivery of a therapeutic to its target site, minimizing off-target accumulation and facilitating patient compliance. As therapeutic modalities expanded beyond small molecules to include nucleic acids, peptides, proteins and antibodies, drug delivery technologies were adapted to address the challenges that emerged. In this Review Article, we discuss seminal approaches that led to the development of successful therapeutic products involving small molecules and macromolecules, identify three drug delivery paradigms that form the basis of contemporary drug delivery and discuss how they have aided the initial clinical successes of each class of therapeutic. We also outline how the paradigms will contribute to the delivery of live-cell therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The ultimate goal of the development of smart nanoparticles is that the payloads can better serve patients: enhance curative effect, reduce toxicity and prolong survival.276”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [276]
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,484
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035389 · Cited by 10,119
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia
Maude, S. L., Laetsch, T. W., Buechner, J., Rives, S., Boyer, M., Bittencourt, H., Bader, P., Verneris, M. R., Stefanski, H. E., Myers, G. D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709866 · Cited by 5,735
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Research works printed but not linked: 2
- Dost, F. H. Der Blutspiegel: Kinetik der Konzentrationsabläufe in der Kreislaufflüssigkeit (Georg Thieme, 1953).
- DeLoach, J. R. & Sprandel, U. (eds) in Bibliotheca Haematologica Vol. 51 (Karger, 1985).
Cited by
Sorted by citations
Drug delivery systems for RNA therapeutics
Paunovska, K., Loughrey, D., & Dahlman, J. E. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-021-00439-4 · Cited by 1,349
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,279
Smart nanoparticles for cancer therapy
Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073
“276 In order to achieve these goals, researchers and medical experts have established various methods to overcome the inherent defects of current drugs.”
BackgroundAdvances in drug delivery systems, challenges and future directions
Ezike, T. C., Okpala, U. S., Onoja, U. L., Nwike, C. P., Ezeako, E. C., Okpara, O. J., Okoroafor, C. C., Eze, S. C., Kalu, O. L., Odoh, E. C., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17488 · Cited by 1,040
“Furthermore, it improves drug solubility, target site accumulation, efficacy, pharmacological activity, pharmacokinetic properties, patient acceptance, and compliance, and reduces drug toxicity [2].”
BackgroundRecent advances in transdermal drug delivery systems: a review
Jeong, W. Y., Kwon, M., Choi, H. E., & Kim, K. S. (2021) · Biomaterials Research · doi:10.1186/s40824-021-00226-6 · Cited by 598
Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems
Baryakova, T. H., Pogostin, B. H., Langer, R., & McHugh, K. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00670-0 · Cited by 566
Evolution of drug delivery systems: From 1950 to 2020 and beyond
Park, H., Otte, A., & Park, K. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.030 · Cited by 507
Scale-up polymeric-based nanoparticles drug delivery systems: Development and challenges
Herdiana, Y., Wathoni, N., Shamsuddin, S., & Muchtaridi, M. (2022) · OpenNano · doi:10.1016/j.onano.2022.100048 · Cited by 335
Stimuli-Responsive Polymer-Based Nanosystems for Cancer Theranostics
Wei, D., Sun, Y., Zhu, H., & Fu, Q. (2023) · ACS Nano · doi:10.1021/acsnano.3c06019 · Cited by 326
Metal–phenolic network composites: from fundamentals to applications
Lin, Z., Liu, H., Richardson, J. J., Xu, W., Chen, J., Zhou, J., & Caruso, F. (2024) · Chemical Society Reviews · doi:10.1039/d3cs00273j · Cited by 299
Biosafety of mesoporous silica nanoparticles; towards clinical translation
Lérida‐Viso, A., Estepa‐Fernández, A., García‐Fernández, A., Martí‐Centelles, V., & Martínez‐Máñez, R. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115049 · Cited by 293
Magneto‐Responsive Microneedle Robots for Intestinal Macromolecule Delivery
Zhang, X., Chen, G., Fu, X., Wang, Y., & Zhao, Y. (2021) · Advanced Materials · doi:10.1002/adma.202104932 · Cited by 267
Metal–organic frameworks for biological applications
Lázaro, I. A., Chen, X., Ding, M., Eskandari, A., Fairen‐Jiménez, D., Giménez‐Marqués, M., Gref, R., Lin, W., Luo, T., & Forgan, R. S. (2024) · Nature Reviews Methods Primers · doi:10.1038/s43586-024-00320-8 · Cited by 277
Recent Applications of PLGA in Drug Delivery Systems
Yang, J., Zeng, H., Luo, Y., Chen, Y., Wang, M., Wu, C., & Hu, P. (2024) · Polymers · doi:10.3390/polym16182606 · Cited by 268
“In recent years, drug delivery technologies have been developed to improve human health in multiple ways, including by enhancing therapeutic delivery to target sites, minimizing off-target accumulation, and improving patient compliance [130].”
BackgroundFerrazzano, L., Catani, M., Cavazzini, A., Martelli, G., Corbisiero, D., Cantelmi, P., Fantoni, T., Mattellone, A., Luca, C. D., Felletti, S., et al. (2022) · Green Chemistry · doi:10.1039/d1gc04387k · Cited by 253
Kuperkar, K. C., Atanase, L. I., Bahadur, A., Crivei, I. C., & Bahadur, P. (2024) · Polymers · doi:10.3390/polym16020206 · Cited by 250
Liu, J., Cabral, H., & Mi, P. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115239 · Cited by 254
Advances in Drug Delivery Systems Based on Red Blood Cells and Their Membrane-Derived Nanoparticles
Nguyen, P. H. D., Jayasinghe, M. K., Le, A. H., Peng, B., & Le, M. T. N. (2023) · ACS Nano · doi:10.1021/acsnano.2c11965 · Cited by 233
Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities
Claridge, B., Lozano, J., Poh, Q. H., & Greening, D. W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.734720 · Cited by 243
Alharbi, W. S., Almughem, F. A., Almehmady, A. M., Jarallah, S. J., Alsharif, W. K., Alzahrani, N. M., & Alshehri, A. A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091475 · Cited by 167
Tumor Abnormality-Oriented Nanomedicine Design
Zhou, Q., Xiang, J., Qiu, N., Wang, Y., Piao, Y., Shao, S., Tang, J., Zhou, Z., & Shen, Y. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00062 · Cited by 203
Biomedical polymers: synthesis, properties, and applications
Chen, W., Chen, Q., Chen, Q., Cui, C., Duan, S., Kang, Y., Liu, Y., Liu, Y., Muhammad, W., Shao, S., et al. (2022) · Science China Chemistry · doi:10.1007/s11426-022-1243-5 · Cited by 197
Li, M., Kim, J., Rha, H., Son, S., Levine, M. S., Xu, Y., Sessler, J. L., & Kim, J. S. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c01231 · Cited by 183
Harnessing artificial intelligence for the next generation of 3D printed medicines
Elbadawi, M., McCoubrey, L. E., Gavins, F. K. H., Ong, J. J., Goyanes, Á., Gaisford, S., & Basit, A. W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.015 · Cited by 188
Biomaterials coating for on-demand bacteria delivery: Selective release, adhesion, and detachment
Liu, J., Li, W., Wang, Y., Ding, Y., Lee, A., & Hu, Q. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101291 · Cited by 171
Let’s talk about sex: Differences in drug therapy in males and females
Madla, C. M., Gavins, F. K. H., Merchant, H. A., Orlu, M., Murdan, S., & Basit, A. W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.014 · Cited by 167
Yi, W., Xiao, P., Liu, X., Zhao, Z., Sun, X., Wang, J., Zhou, L., Wang, G., Cao, H., Wang, D., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01250-1 · Cited by 178
“As treatment methods evolve from small molecule chemicals to nucleic acids, peptides, antibodies, and living cells, DDSs are facing numerous obstacles.(16) For example, nanomedicines can transport therapeutic drugs to the target site through enhanced permeability and retention (EPR) effects, but they still accumulate…”
BackgroundVijayakanth, T., Shankar, S., Finkelstein‐Zuta, G., Rencus‐Lazar, S., Gilead, S., & Gazit, E. (2023) · Chemical Society Reviews · doi:10.1039/d3cs00202k · Cited by 162
Bioorthogonal chemistry for prodrug activation in vivo
Fu, Q., Shen, S., Sun, P., 谷, 知., Bai, Y., Wang, X., & Liu, Z. (2023) · Chemical Society Reviews · doi:10.1039/d2cs00889k · Cited by 158
Ma, X., Kuang, L., Yin, Y., Tang, L., Zhang, Y., Fan, Q., Wang, F., Dong, Z., Wang, W., Yin, T., et al. (2023) · ACS Nano · doi:10.1021/acsnano.2c09033 · Cited by 155
Bio-Inspired Nanomaterials for Micro/Nanodevices: A New Era in Biomedical Applications
Harun‐Ur‐Rashid, M., Jahan, I., Foyez, T., & Imran, A. B. (2023) · Micromachines · doi:10.3390/mi14091786 · Cited by 163
CARBON DOTS: Bioimaging and Anticancer Drug Delivery
Bartkowski, M., Zhou, Y., Mustafa, M. N. A., Eustace, A. J., & Giordani, S. (2024) · Chemistry - A European Journal · doi:10.1002/chem.202303982 · Cited by 149
Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment
Coghi, P. S., Li, J., Hosmane, N. S., & Zhu, Y. (2023) · Medicinal Research Reviews · doi:10.1002/med.21964 · Cited by 142
“(1) Proteolitic instability and poor stability(106); (2) Rapid clearance (short half‐life)(101,106); (3) High cost(106); (4) Simpler synthetic process compared with biologics; (5) Poor bioavailability.(106) Uptake by specific transport (i.”
BackgroundStimulus-responsive self-assembled prodrugs in cancer therapy
Dong, X., Brahma, R. K., Fang, C., & Yao, S. Q. (2022) · Chemical Science · doi:10.1039/d2sc01003h · Cited by 141
Synthetic Polymers for Drug, Gene, and Vaccine Delivery
Xu, Y., Chen, J., Ding, J., Sun, J., Song, W., Tang, Z., Xiao, C., & Chen, X. (2025) · Polymer science & technology. · doi:10.1021/polymscitech.5c00010 · Cited by 140
Qi, J., Jia, S., Kang, X., Wu, X., Hong, Y., Shan, K., Kong, X., Wang, Z., & Ding, D. (2022) · Advanced Materials · doi:10.1002/adma.202203309 · Cited by 137
Aptamer-Based Targeted Delivery of Functional Nucleic Acids
Xie, S., Sun, W., Fu, T., Liu, X., Chen, P., Qiu, L., Qu, F., & Tan, W. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c00841 · Cited by 130
Kansız, S., & Elçin, Y. M. (2023) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2023.102930 · Cited by 133
Drug Delivery Systems in Regenerative Medicine: An Updated Review
Mansour, A., Romani, M., Acharya, A. B., Rahman, B., Verron, É., & Badran, Z. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020695 · Cited by 138
“, cancer and invasive fungal infections) [7].”
Electrospun nanofibers for drug delivery applications: Methods and mechanism
Abdulhameed, M. M., Khan, S. A. P. M., Thamer, B. M., Nirmala, R., El‐Hamshary, H., & El-Newehy, M. H. (2022) · Polymers for Advanced Technologies · doi:10.1002/pat.5884 · Cited by 127
Roll-to-roll, high-resolution 3D printing of shape-specific particles
Kronenfeld, J. M., Rother, L., Saccone, M. A., Dulay, M. T., & DeSimone, J. M. (2024) · Nature · doi:10.1038/s41586-024-07061-4 · Cited by 123
“…of micrometres to nanometres are ubiquitous key components in many advanced applications including biomedical devices 1,2 , drug-delivery systems 3–5, 15 , Traditional particle fabrication methods range from milling and emulsification techniques to advanced moulding and flow lithography, and…”
Strategic Approaches to Improvise Peptide Drugs as Next Generation Therapeutics
Barman, P., Joshi, S., Sharma, S., Preet, S., Sharma, S., & Saini, A. (2023) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-023-10524-3 · Cited by 127
Novel Drug Delivery Systems: An Important Direction for Drug Innovation Research and Development
Chen, Q., Yang, Z., Liu, H., Man, J., Oladejo, A. O., Ibrahim, S., Wang, S., & Hao, B. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16050674 · Cited by 134
“…approaches, DDS is dedicated to the development of drug delivery systems and devices that can modulate the metabolism, potency, toxicity, immunogenicity, and biorecognition of drugs, thereby enhancing the microenvironment in which the drug operates and facilitating its uptake by the body [1].”
BackgroundRecent Advances in Pro-PROTAC Development to Address On-Target Off-Tumor Toxicity
Chen, C., Yang, Y., Wang, Z., Li, H., Dong, C., & Zhang, X. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00302 · Cited by 118
Balcerak, A., Dzwonkowska-Zarzycka, M., & Kabatc, J. (2024) · Materials · doi:10.3390/ma17174255 · Cited by 118
“Significantly, the application of smart polymers in the production of various types of sensors can enhance their effectiveness of working [140].”
BackgroundKumar, V., Lakkaboyana, S. K., Sharma, N., Chakraborty, P., Umesh, M., Pasrija, R., Thomas, J. B., Kalebar, V. U., Iyyappan, J., Awasthi, M. K., et al. (2023) · Case Studies in Chemical and Environmental Engineering · doi:10.1016/j.cscee.2023.100363 · Cited by 116
Discovery and delivery strategies for engineered live biotherapeutic products
Heavey, M. K., Durmusoglu, D., Crook, N., & Anselmo, A. C. (2021) · Trends in biotechnology · doi:10.1016/j.tibtech.2021.08.002 · Cited by 116
Self-citationArtificial Intelligence‐Driven Nanoarchitectonics for Smart Targeted Drug Delivery
Bae, H., Ji, H., Konstantinov, K., Sluyter, R., Ariga, K., Kim, J. H., & Kim, J. H. (2025) · Advanced Materials · doi:10.1002/adma.202510239 · Cited by 125
Triplet–triplet annihilation photon upconversion-mediated photochemical reactions
Huang, L. F., & Han, G. (2024) · Nature Reviews Chemistry · doi:10.1038/s41570-024-00585-3 · Cited by 112
Qin, D., Wang, N., You, X.-G., Zhang, A.-D., Chen, X., & Liu, Y. (2021) · Biomaterials Science · doi:10.1039/d1bm01294k · Cited by 113
The emerging role of nanotechnology in plant genetic engineering
Squire, H. J., Tomatz, S., Voke, E., Grandío, E. G., & Landry, M. P. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00037-5 · Cited by 110
Guo, R., Zhang, X., Fan, P., Song, B., Li, Z., Duan, Z., Qiao, Z., & Wang, H. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202111839 · Cited by 109
Stimuli-Responsive Nanomedicines for the Treatment of Non-cancer Related Inflammatory Diseases
Yang, J., Rieux, A. D., & Malfanti, A. (2025) · ACS Nano · doi:10.1021/acsnano.5c00700 · Cited by 116
Overcoming barriers for intra-articular delivery of disease-modifying osteoarthritis drugs
Gao, J., Xia, Z. J., Baby, H. M., Joseph, J., Luo, J. N., & Joshi, N. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.12.004 · Cited by 108
Sun, Y., Wang, Z., Gu, J., Xia, L., Cao, Y., Zhu, X., Wen, H., Ouyang, S., Liu, R., Li, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46046-9 · Cited by 126
“…GI diseases put forward urgent requirements for providing other functions of MagCaps, such as the active targeted delivery in a large spatialarea 42 , site-directed drug releasefor reducing drug dosage and preventing drug side effects 56 , and sampling for biological information in GI tract 6,7 .”
MLCPP 2.0: An Updated Cell-penetrating Peptides and Their Uptake Efficiency Predictor
Manavalan, B., & Patra, M. C. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167604 · Cited by 104
Albumin-based delivery systems: Recent advances, challenges, and opportunities
Murphy, G., Brayden, D. J., Cheung, D. L., Liew, A., Fitzgerald, M. T., & Pandit, A. S. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.01.035 · Cited by 107
Boczar, D., & Michalska, K. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071389 · Cited by 104
“Due to the high costs associated with the development of innovative drugs, a very long time to introduce them to the market, and a huge risk of failure in clinical trials, more and more work is focused on the development of new drug-delivery systems [1] based on existing active pharmaceutical ingredients (APIs) with a…”
BackgroundAntibody-based drug delivery systems for cancer therapy: Mechanisms, challenges, and prospects
Chen, Z., Kankala, R. K., Yang, Z., Li, W., Xie, S., Li, H., Chen, A., & Zou, L. (2022) · Theranostics · doi:10.7150/thno.72594 · Cited by 108
“Hence, inhalation powder of human insulin and the anti-IL-13 antigen-binding fragment is being developed and applied clinically [51].”
BackgroundMethodInfluentialSmart hydrogel: A new platform for cancer therapy
Li, G., Fu, Z.-M., Li, H., Wei, R., Guo, J., Wang, H., & Qi, J. (2025) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2025.103470 · Cited by 100
Long, X., Liu, M., Nan, Y., Chen, Q., Xiao, Z., Xiang, Y., Ying, X., Sun, J., Huang, Q., & Ai, K. (2024) · Advanced Materials · doi:10.1002/adma.202308239 · Cited by 97
Exploring the impact of physicochemical properties of liposomal formulations on their in vivo fate
Sheikholeslami, B., Lam, N. W., Dua, K., & Haghi, M. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120574 · Cited by 100
Kim, M., Shin, M., Zhao, Y., Ghosh, M., & Son, Y. (2024) · Small Science · doi:10.1002/smsc.202400280 · Cited by 97
Sulfobutylether-β-cyclodextrin: A functional biopolymer for drug delivery applications
Pardeshi, C. V., Kothawade, R. V., Markad, A. R., Pardeshi, S. R., Kulkarni, A. D., Chaudhari, P. J., Longhi, M. R., Dhas, N. L., Naik, J., Surana, S. J., et al. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.120347 · Cited by 92
Cellular landscaping of cisplatin resistance in cervical cancer
Bhattacharjee, R., Dey, T., Kumar, L., Kar, S., Sarkar, R., Ghorai, M., Malik, S., Jha, N. K., Vellingiri, B., Kesari, K. K., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113345 · Cited by 93
Regulatory safety evaluation of nanomedical products: key issues to refine
de Jong, W. H., Geertsma, R. E., & Borchard, G. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01208-4 · Cited by 93
Cell-Penetrating Peptides (CPPs) as Therapeutic and Diagnostic Agents for Cancer
Bottens, R. A., & Yamada, T. (2022) · Cancers · doi:10.3390/cancers14225546 · Cited by 90
Degrader–Antibody Conjugates: Emerging New Modality
Hong, K. B., & An, H. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01791 · Cited by 93
Advancement of Nanofibrous Mats and Common Useful Drug Delivery Applications
Owida, H. A., Al-Nabulsi, J., Alnaimat, F., Sharah, A. A., Al-Ayyad, M. S., Turab, N. M., & Abdullah, M. (2022) · Advances in Pharmacological and Pharmaceutical Sciences · doi:10.1155/2022/9073837 · Cited by 88
Gómez-Lázaro, L., Martín‐Sabroso, C., Aparicio-Blanco, J., & Torres‐Suárez, A. I. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16010103 · Cited by 88
“Despite the promising benefits of these formulations at a preclinical level, only a few colloidal systems are approved for drug delivery in comparison with macro-sized dosage forms [18,19].”
BackgroundBiomaterials-mediated CRISPR/Cas9 delivery: recent challenges and opportunities in gene therapy
Dubey, A. K., & Mostafavi, E. (2023) · Frontiers in Chemistry · doi:10.3389/fchem.2023.1259435 · Cited by 96
“To increase the effectiveness and speci fi city of CRISPR/Cas9 delivery, a variety of biomaterial-based delivery systems, including nanoparticles, liposomes, and hydrogels, have been investigated (Vargason et al., 2021; Bhattacharjee et al., 2022).”
BackgroundLiposomal Formulations: A Recent Update
Agrawal, S. S., Baliga, V., & Londhe, V. Y. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics17010036 · Cited by 92
“These innovative liposomes are designed to release their contents in response to specific triggers such as changes in pH or the presence of specific enzymes [136].”
Dogbey, D. M., Torres, V. E. S., Fajemisin, E. A., Mpondo, L., Ngwenya, T., Akinrinmade, O. A., Perriman, A. W., & Barth, S. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-023-01362-3 · Cited by 97
Microrobots for Biomedicine: Unsolved Challenges and Opportunities for Translation
Lee, J. G., Raj, R. R., Day, N. B., & Shields, C. W. (2023) · ACS Nano · doi:10.1021/acsnano.3c03723 · Cited by 89
Bioresponsive drug delivery systems
Alavi, S. E., Alharthi, S., Alavi, S. E., Raza, A., & Shahmabadi, H. E. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103849 · Cited by 85
Living Leukocyte‐Based Drug Delivery Systems
Chen, Y., Qin, D., Zou, J., Li, X., Guo, X. D., Tang, Y., Chuang, L. I. U., Chen, W., Kong, N., Zhang, C. Y., et al. (2022) · Advanced Materials · doi:10.1002/adma.202207787 · Cited by 85
Sridhar, V., Yıldız, E., Rodríguez‐Camargo, A., Lyu, X., Yao, L., Wrede, P., Aghakhani, A., Akolpoglu, M. B., Podjaski, F., Lotsch, B. V., et al. (2023) · Advanced Materials · doi:10.1002/adma.202301126 · Cited by 83
Molecular insights of exercise therapy in disease prevention and treatment
Walzik, D., Chirino, T. Y. W., Zimmer, P., & Joisten, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01841-0 · Cited by 95
“401 In contrast, other compounds have yielded promising results in animal models but have not found their way into clinical therapy so far.”
ResultFunctionalization of luminescent lanthanide complexes for biomedical applications
Xian, T., Meng, Q. Y., Gao, F., Hu, M., & Wang, X. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214866 · Cited by 82
Liu, T., Du, Y., Yan, Y., Song, S., Qi, J., Xia, X., Hu, X., Chen, Q., Liu, J., Zeng, X., et al. (2023) · Materials Today · doi:10.1016/j.mattod.2022.12.009 · Cited by 82
Exploring and Analyzing the Systemic Delivery Barriers for Nanoparticles
Wang, L., Quine, S., Frickenstein, A. N., Lee, M., Yang, W., Sheth, V. M., Bourlon, M. D., He, Y., Lyu, S., Garcia‐Contreras, L., et al. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202308446 · Cited by 84
Bian, H., Ma, D., Nan, Y., Kim, M. H., Kim, S. H., Chen, X., Peng, X., & Yoon, J. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.216551 · Cited by 82
Advancing drug delivery to articular cartilage: From single to multiple strategies
Zhao, T., Li, X., Li, H., Deng, H., Li, J., Yang, Z., He, S., Jiang, S., Sui, X., Guo, Q., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.11.021 · Cited by 83
“A proper drug delivery carrier retains agent activity, protects agents from clearance, controls agent release, and delivers agents to specific cells or damaged tissues 49 .”
BackgroundAn, Y., Ji, C., Zhang, H., Jiang, Q., Maitz, M. F., Pan, J., Luo, R., & Wang, Y. (2025) · ACS Nano · doi:10.1021/acsnano.4c16280 · Cited by 82
Stimuli‐Responsive Silica Silanol Conjugates: Strategic Nanoarchitectonics in Targeted Drug Delivery
Mohanan, S., Guan, X., Liang, M., Karakoti, A. S., & Vinu, A. (2023) · Small · doi:10.1002/smll.202301113 · Cited by 83
Emerging delivery approaches for targeted pulmonary fibrosis treatment
Diwan, R., Bhatt, H., Beaven, E., & Nurunnabi, M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115147 · Cited by 81
Biodegradable Materials for Transient Organic Transistors
Stephen, M., Nawaz, A., Lee, S. Y., Sonar, P. M., & Leong, W. L. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202208521 · Cited by 79
Photoresponsive Drug Delivery Systems: Challenges and Progress
Yang, Y., Long, K., Chu, Y., Lu, H., Wang, W., & Zhan, C. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202402975 · Cited by 77
Ragelle, H., Rahimian, S., Guzzi, E. A., Westenskow, P. D., Tibbitt, M. W., Schwach, G., & Langer, R. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113990 · Cited by 76
Constantino, V. R. L., Figueiredo, M. P., Magri, V. R., Eulálio, D., Cunha, V. R. R., Alcântara, A. C. S., & Perotti, G. F. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020413 · Cited by 76
Wang, Y., Shi, J., Xin, M., Kahkoska, A. R., Wang, J., & Gu, Z. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01230-6 · Cited by 82
“By offering spatiotemporal control over the distribution and release of drugs, advanced drug-delivery systems improve the efficacy of treatments and reduce their side effects 1–5 .”
From Nature‐Sourced Polysaccharide Particles to Advanced Functional Materials
Ma, Y., Morozova, S. M., & Kumacheva, E. (2024) · Advanced Materials · doi:10.1002/adma.202312707 · Cited by 74
Innovative transdermal drug delivery systems: Benefits, challenges, and emerging application
Shah, S. W. A., Li, X., Yuan, H., Shen, H., Quan, S., Pan, G., Ishfaq, M., Shah, A. U., Xie, H., & Shao, J. (2025) · BMEMat · doi:10.1002/bmm2.70001 · Cited by 80
Wang, S., Wang, Z., Li, Z., Zhang, X., Zhang, H., Zhang, T., Meng, X., Sheng, F., & Hou, Y. (2022) · Science Advances · doi:10.1126/sciadv.abn3883 · Cited by 72
Delivering living medicines with biomaterials
Harimoto, T., Jung, W., & Mooney, D. J. (2025) · Nature Reviews Materials · doi:10.1038/s41578-024-00766-y · Cited by 79
“Typically, small-molecule drugs (less than ~60 kDa) are metabolized by enzymes such as cytochrome P450 and are rapidly cleared via renal filtration 10,179 .”
Ji, C., Qiu, M., Ruan, H., Li, C., Cheng, L., Wang, J., Li, C., Jin, Q., Cui, W., & Deng, L. (2022) · Advanced Science · doi:10.1002/advs.202105194 · Cited by 69
Harnessing reactive oxygen/nitrogen species and inflammation: Nanodrugs for liver injury
Liu, M., Huang, Q., Zhu, Y., Chen, L., Li, Y., Gong, Z., & Ai, K. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100215 · Cited by 70
Lipid Nanoparticles: A Novel Gene Delivery Technique for Clinical Application
Mashima, R., & Takada, S. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44100341 · Cited by 73
“When extended half-life is desired, 2′-O-methylation and 5′/3′-phosphorothioation are performed [18,21,22] (Figure 2C).”
BackgroundCardoso, R. V., Pereira, P. R., Freitas, C. S., & Paschoalin, V. M. F. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122808 · Cited by 69
“However, since the targets for small therapeutic molecules represent only 2–5% of the human genome products, the search for alternative therapeutics capable of expanding the number of new targets has increased the number of studies on natural therapeutic biomolecules, comprising searches in diverse classes, including…”
BackgroundNanocarriers for oral delivery of biologics: small carriers for big payloads
Cao, Y., Rewatkar, P. V., Wang, R., Hasnain, S. Z., Popat, A., & Kumeria, T. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.08.005 · Cited by 68
Metadata
- Authors
- Vargason, A. M., Anselmo, A. C., & Mitragotri, S.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Harvard University (US)
- Corresponding author
- Mitragotri, Samir
- Venue
- Nature Biomedical Engineering
- Published
- 2021-04-01
- Volume
- 5
- Issue
- 9
- Pages
- 951-967
- ISSN
- 2157-846X (ISSN-L)
- OpenAlex
- W3143156272
- Cited by
- 1,361
- References
- 275
- Citations by year
- 2026: 170 · 2025: 314 · 2024: 366 · 2023: 293 · 2022: 170 · 2021: 48
- FWCI
- 19.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Nature Biomedical Engineering (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Science Foundation (DGE-1650116)
- U.S. Department of Health & Human Services | National Institutes of Health (R35GM137898, 1R01HL143806-01)
- United States Department of Defense | Defense Threat Reduction Agency (HDTRA1-15-1-0045)
- U.S. Department of Defense (W81XWH-19-2-0011)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- drug delivery technology, small molecules, macromolecules, nucleic acids, proteins, immunoglobulins, medication adherence
- MeSH terms
- Pharmaceutical Preparations, Humans, Nucleic Acids, Peptides, Proteins, Drug Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
